Morgan Stanley Vivos Therapeutics, Inc. Transaction History

Morgan Stanley

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.31 - $0.55 $82 - $146	267 Added 19.07%	1,667 $0
Q4 2022 Feb 14, 2023	SELL	$0.35 - $20.75 $0 - $20	-1 Reduced 0.07%	1,400 $0
Q3 2022 Nov 14, 2022	SELL	$0.83 - $21.25 $829 - $21,228	-999 Reduced 41.63%	1,401 $1,000
Q2 2022 Oct 27, 2022	SELL	$1.12 - $2.18 $1,367 - $2,661	-1,221 Reduced 33.72%	2,400 $3,000
Q2 2022 Aug 15, 2022	SELL	$1.12 - $2.18 $1,367 - $2,661	-1,221 Reduced 33.72%	2,400 $3,000
Q1 2022 Oct 27, 2022	BUY	$1.63 - $3.63 $1,990 - $4,432	1,221 Added 50.88%	3,621 $9,000
Q1 2022 May 13, 2022	BUY	$1.63 - $3.63 $1,988 - $4,428	1,220 Added 50.81%	3,621 $9,000
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.11 $290 - $530	-129 Reduced 5.1%	2,401 $5,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $5.9 $6,856 - $14,927	2,530 New	2,530 $10,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.